A new anatomically-shaped, silicone gel-filled implant option for their practice’s breast enhancement patients. In February, the U.S. Food and Drug Administration approved the Natrelle® 410 breast implant, which can be used in a variety of breast procedures including breast augmentation and breast reconstruction.
Manufactured by Allergan, Inc., Natrelle® 410 silicone breast implants are engineered to complement a woman’s natural curves with an anatomically shaped silhouette. Natrelle® 410 silicone implants are already the #1 surgeon-selected implant in Europe and Canada and have been used successfully in those regions for 20 years.
The rate of rupture is reduced with this kind of implants according to Allergan
As a result of a recent advancement in silicone gel technology, Natrelle® 410 implants contain more cross-linking (the bonds that link silicone chains together) compared to the silicone gel used in Allergan’s previously approved Natrelle® implant. The result is a firmer implant that has a reduced rate of rupture and is better able to hold a natural-looking form over a longer period of time.
The Waldorf Center for Plastic Surgery published an artilce in Marketwire.com that explains that according to Drs. Waldorf and O’Brien, a couple of doctors based in Portland USA, the Natrelle® 410 silicone implants are form-stable and will enable the plastic surgeons to better treat some of their breast augmentation and breast reconstruction patients. These implants will provide a more consistent shape — especially in the upper pole of the breast — while reducing the problem of rippling or wrinkling. Over a seven-year trial period, these implants also displayed zero gel migrations in ruptured implants.